Evaluation of the relationship between a pharmaceutical compound's distribution coefficient, log D and adsorption loss to polypropylene in urine and CSF

Bioanalysis

Volumn 2, Issue 4, 2010, Pages 755-767

  Kadar, Eugene P ^a   Su, Yi ^a   Zhang, Yizhong ^a   Tweed, Joseph ^a   Wujcik, Chad E ^b  

^a PFIZER INC   (United States)

^b MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2[(4' TRIFLUOROMETHYL BIPHENYL 2 CARBONYL)AMINO]QUINOLINE 6 CARBOXYLIC ACID(PENTYLCARBAMOYL PHENYL METHYL)AMIDE; 3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; 4 PIPERIDIN 1 YL BUT 2 ENOIC ACID[4 (3 CHLORO 4 FLUOROPHENYLAMINO 7 METHOXY QUINAZOLIN 6 YL)]AMIDE; 5 [2 [4 (3,4 DIFLUORO PHENOXY)PHENYL]ETHYLSULFAMOYL] 2 METHYL BENZOIC ACID; 5 [4 (4 ETHYL BENZYLSULFANYL)PHENYLSULFAMOYL] 2 METHYL BENZOIC ACID; ACETIC ACID 1 [5 (6 DIMETHYLAMINO 2 METHYL PYRIDIN 3 YL) 3,6 DIETHYL PYRAZIN 2 YL AMINO]INDAN 2 YL ESTER; ACETONITRILE; CHEMICAL COMPOUND; N BENZYL 2 [4 (1H INDOL 3 YL METHYL) 5 OXO 1 PHENYL 4,5 DIHYDRO 2,3,6,10B TETRAAZA BENZ[E]AZULEN 6 YL] N ISOPROPYL ACETAMIDE; POLYPROPYLENE; UNCLASSIFIED DRUG; WATER; 3 ((3 CHOLAMIDOPROPYL)DIMETHYLAMMONIUM) 1 PROPANESULFONATE; 3-((3-CHOLAMIDOPROPYL)DIMETHYLAMMONIUM)-1-PROPANESULFONATE; CHOLIC ACID DERIVATIVE; DRUG; SOLVENT;

ADSORPTION; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYDROPHOBICITY; MALE; MASS SPECTROMETRY; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; REVERSED PHASE LIQUID CHROMATOGRAPHY; URINE PH; CHEMISTRY; PH; URINE;

ADSORPTION; CHOLIC ACIDS; HUMANS; HYDROGEN-ION CONCENTRATION; PHARMACEUTICAL PREPARATIONS; POLYPROPYLENES; SOLVENTS;

EID: 79952480865     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.1     Document Type: Article

References (30)

1. Blanc JA, Manneh VA, Ernst R et al. Adsorption losses from urine-based cannabinoid calibrators during routine use. Clin. Chem. 39(8), 1705-1712 (1993). (Pubitemid 23246006)
2. Xu Y, Du L, Rose MJ, Fu I, Woolf EJ, Musson DG. Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine. J. Chromatogr. B 818, 241-248 (2005). (Pubitemid 40331830)
3. Groff M, Riffel K, Song H, Lo M. Stabilization and determination of a PPAR agonist in human urine using automated 96-well liquid-liquid extraction and liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 842, 122-130 (2006). (Pubitemid 44416632)
4. Fisher AL, DePuy E, Shih T et al. Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation. J. Pharmaceut. Biomed. 26, 739-752 (2001). (Pubitemid 32971686)
5. Schwartz M, Kline W, Matuszewski B. Determination of a cyclic hexapeptide (L-743 872), a novel pneumocandin antifungal agent in human plasma and urine by high-performance liquid chromatography with fluorescence detection. Anal. Chim. Acta. 352, 299-307 (1997). (Pubitemid 27522832)
6. Tietz Textbook of Clinical Chemistry (3rdEdition). Burtis CA, Ashwood ER (Eds). WB Saunders Company, PA, USA, 514 (1999).
7. Gillenwater JY, Grayhack JT, Howards SS et al. Adult and Pediatric Urology (4th Edition, Volume 1). Lippincott Williams & Wilkins, USA, 356 (2001).
8. Yuan X, Russel T, Wood G, Desiderio DM. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 23, 1185-1196 (2002).
9. Lázníĉek M, Lázníĉková A. The effect of lipophilicity on the protein binding and blood cell uptake of some acidic drugs. J. Pharm. Biomed. Anal. 13, 823-828 (1995).
10. Yamazaki K, Kanaoka M. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds. J. Pharm. Sci. 1480-1494 (2004). (Pubitemid 38725020)
11. Yahya AM, McElnay JC, D"Arcy PF. Drug sorption to glass and plastics. Drug Metab. Drug Interact. 6, 1-45 (1988). (Pubitemid 19044623)
12. Piraprez G, Herent M, Collin S, Determination of the lipophilicity of aroma compounds by RP-HPLC. Flavour Fragr. 13, 400-408 (1998). (Pubitemid 29020855)
13. Fura A, Harper TW, Zhang H, Fung L, Shyu W. Shift in pH of biological fluids during storage and processing: effect on bioanalysis. J. Pharm. Biomed. Anal. 32, 513-522 (2003). (Pubitemid 38021842)
14. Siesjö BK. The regulation of cerebrospinal fluid pH. Kidney Int. 1 (1972) 360-374.
15. Scherrer RA, Howard SM. Use of distribution coefficients in quantitative structure-activity relationships. J. Med. Chem. 20, 53-58 (1977). (Pubitemid 8020532)
16. ACD/LogD Suite Version 11.0 for Microsoft Windows Reference Manual Comprehensive Interface Description.
17. Jenke DR, Hayward DS, Kenley RA. Liquid chromatographic measurement of solute solvent/solvent partition coefficients: application to solute/container interactions. J. Chromatogr. Sci. 28, 609-612 (1990).
18. Pitt CG, Bao YT, Andrady AL, Samuel PNK. The correlation of polymer-water and octanol-water partition coefficients: estimation of drug solubilities in polymers. Int. J. Pharm. 45, 1-11 (1988).
19. Illum L, Bundgaard H. Sorption of drugs by plastic infusion bags. Int. J. Pharm. 10 (1982) 339-351 (Pubitemid 12046329)
20. Nasim K, Meyer MC, Autian J. Permeation of aromatic organic compounds from aqueous solutions through polyethylene. J. Pharm. Sci. 61/11, 1775-1780 (1972).
21. Jordan DO, Polack AE. Permeation of organic solutes in aqueous solution through polyethylene membranes. II. Effect of concentration, temperature, and other variables. Aust J. Pharm. Sci. 1, 82-87 (1972).
22. Serota DG, Meyer MC, Autian J. Effects of structure on permeability of substituted anilines from aqueous solutions through polyethylene. J. Pharm. Sci. 61/3, 416-419 (1972).
23. Kadar EP, Wujcik CE. Remediation of undesirable secondary interactions encountered in hydrophilic interaction chromatography during development of a quantitative LC-MS/MS assay for a dipeptidyl peptidase IV (DPP-IV) inhibitor in monkey serum. J. Chromatogr. B 877, 471-476 (2009).
24. Wilson DM, Bruce J, Eddy J, Perkins JR. Evaluation of non-specific binding in several different matrices: a case study. (Poster 110). Presented at: Seventh Annual Land O"Lakes Bioanalytical Conference. 10-14 July 2006, Merrimac, WI, USA.
25. Cappiello A, Famiglini G, Palma P, Pierini E, Termopoli V, Trufelli H. Overcoming matrix effects in liquid chromatography-mass spectrometry. Anal. Chem. 80(23), 9343-9348 (2008).
26. Sangster T, Spence M, Sinclair P, Payne R, Smith C. Unexpected observation of ion suppression in a liquid chromatography/ atmospheric pressure chemical ionization mass spectrometric bioanalytical method. Rapid Commun. Mass. Spectrom. 18(12), 1361-1364 (2004). (Pubitemid 38843160)
27. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75, 3019-3030 (2003). (Pubitemid 36830428)
28. Avery M. Quantitative characterization of differential ion suppression on liquid chromatography/atmospheric pressure ionization mass spectrometric bioanalytical methods. Rapid Commun. Mass Spectrom. 17, 197-201 (2003). (Pubitemid 36164165)
29. Metrangolo P, Resnati G. Halogen versus hydrogen. Science 321, 918-919 (2008).
30. Schwarzenbach R, Gschwend P, Imboden D. Environmental Organic Chemistry (2nd Edition). John Wiley & Sons Inc., NJ, USA, 229 (2003).